🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07499817
Recruiting Phase 3

Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

NCT07499817 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 3
Started
2023-10-01
Last updated
2026-03-30

Condition(s) studied

Embryo TransferIVFInfertility

Investigational drug(s) / intervention(s)

pentoxifylline 400 mg →(control)

pentoxifylline 400 mg: Once daily in form of (Trental ® Sanofi co.) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone.

(control): estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) whitepills starting dose is one pill T.I.D

Study summary

The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
43 Years
Healthy volunteers
No
Inclusion Criteria: * as good quality day five frozen embryos. Exclusion Criteria: * history of endocrine diseases, * history of any previous surgery that couldm compromise the integrity of endometrium, * cardiovascular, renal and liver diseases,

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beni-suef university Hospital Banī Suwayf Beni Suweif Governorate Recruiting

More Beni-Suef University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07499817 on ClinicalTrials.gov ↗ ← All trials in Egypt